InvestorsHub Logo
Followers 165
Posts 19846
Boards Moderated 2
Alias Born 12/09/2004

Re: BIOChecker4 post# 463168

Tuesday, 07/02/2024 5:15:06 PM

Tuesday, July 02, 2024 5:15:06 PM

Post# of 463229
Biogen looked at 2-73 for MS and that was years ago before much of the positive data was developed.

All of the major BPs are watching Anavex to see what finally happens with the MAA and NDA. That will have a direct bearing on AD research going forward and as such their drug pipelines.

Whether they want to buy out Anavex, partner with Anavex, or continue to pursue their chosen research/drug development direction will be an individual BP choice.

Once the 2-73 MOA is proven they will all take notice.

Nunc est Bibendum

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News